Skip to content
lifestyle.ukuncut.org.uk
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
OKYO Pharma LTD
OKYO Pharma Reports New Phase 2 Data Demonstrating Meaningful Improvements in Patient-Reported Quality of Life Outcomes with Urcosimod in Neuropathic Corneal Pain
March 18, 2026
OKYO Abstract Selected for Presentation at Premier Global Ophthalmology Congress
February 23, 2026
OKYO Pharma Announces Pricing of $20 Million Public Offering of Ordinary Shares
February 12, 2026
OKYO Pharma Announces Public Offering of Ordinary Shares
February 12, 2026
OKYO Pharma Announces Transition of At-The-Market Equity Offering Facility to Leerink Partners
February 11, 2026
OKYO Pharma Strengthens World Class Leadership Team with Appointment of Flavio Mantelli, MD, PhD as Chief Medical Officer
February 10, 2026
←
Previous Page
1
2